Analyst Consensus ?
ConsensusHold34 ratings
Bullish1132.4%
Neutral2264.7%
Bearish12.9%
FN2 Earnings Intelligence
Marsh & McLennan Companies, Inc. analyst ratings
Marsh & McLennan Companies, Inc. (MRSH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$192.19Previous close
$135Low
$200.9Average
$256High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Jul 27, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 22, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 22, 2026 |
| Citigroup | Neutral | Buy | Downgrade | Jul 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 13, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 10, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 6, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | May 26, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Apr 17, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Apr 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 8, 2026 |
| Raymond James | Strong Buy | Outperform | Upgrade | Feb 17, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 30, 2026 |
| TD Cowen | Hold | Hold | Maintain | Nov 3, 2025 |
| Goldman Sachs | Neutral | Sell | Upgrade | Oct 20, 2025 |
| Jefferies | Hold | Hold | Maintain | Oct 5, 2023 |
| BMO Capital | Market Perform | Market Perform | Maintain | May 14, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 29, 2023 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Nov 7, 2022 |
| MKM Partners | Neutral | Neutral | Maintain | Apr 30, 2020 |
| CFRA | Buy | Hold | Upgrade | Apr 29, 2020 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jun 12, 2019 |
| Compass Point | Neutral | Neutral | Maintain | Jan 15, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 26, 2018 |
| Deutsche Bank | Hold | Buy | Downgrade | Oct 3, 2017 |
| Sandler O'Neill | Buy | Hold | Upgrade | Nov 7, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 4, 2015 |
| Keefe, Bruyette& Woods | Market Perform | Market Perform | Maintain | Feb 8, 2015 |
| Macquarie | Neutral | Outperform | Downgrade | Sep 24, 2014 |
| Evercore Partners | Overweight | Overweight | Maintain | Jul 9, 2014 |
| Nomura | Neutral | Neutral | Maintain | Mar 11, 2014 |
| Miller Tabak | Hold | Buy | Downgrade | Oct 3, 2013 |
| Guggenheim | Buy | Buy | Maintain | Sep 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $192.19. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $216 | $184.62 | +12.4% | Jul 27, 2026 |
| Mizuho Securities | Yaron Kinar | $201 | $181.59 | +4.6% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $188 | $181.59 | -2.2% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $180 | $182.22 | -6.3% | Jul 21, 2026 |
| Evercore ISI | Analyst unavailable | $234 | $179.91 | +21.8% | Jul 10, 2026 |
| Mizuho Securities | Analyst unavailable | $197 | $179.05 | +2.5% | Jul 9, 2026 |
| UBS | Analyst unavailable | $212 | $177.18 | +10.3% | Jul 8, 2026 |
| Morgan Stanley | Analyst unavailable | $175 | $178.54 | -8.9% | Jul 6, 2026 |
| UBS | Brian Meredith | $203 | $162.52 | +5.6% | Jun 9, 2026 |
| Piper Sandler | Analyst unavailable | $182 | $164.11 | -5.3% | May 26, 2026 |
| UBS | Analyst unavailable | $180 | $163.38 | -6.3% | May 21, 2026 |
| Mizuho Securities | Analyst unavailable | $193 | $171.93 | +0.4% | Apr 13, 2026 |
| Raymond James | Strong Buy | $225 | $174.06 | +17.1% | Feb 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $212 | $190.46 | +10.3% | Feb 2, 2026 |
| Mizuho Securities | Analyst unavailable | $213 | $188.19 | +10.8% | Feb 2, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $208 | $182.7 | +8.2% | Jan 14, 2026 |
| Wells Fargo | Elyse Greenspan | $199 | $185.63 | +3.5% | Jan 13, 2026 |
| Barclays | Alex Scott | $210 | $182.9 | +9.3% | Jan 8, 2026 |
| Goldman Sachs | Robert Cox | $199 | $182.9 | +3.5% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $236 | $182.65 | +22.8% | Jan 7, 2026 |
| Morgan Stanley | Bob Huang | $190 | $187.28 | -1.1% | Dec 16, 2025 |
| Mizuho Securities | Analyst unavailable | $212 | $187.28 | +10.3% | Dec 15, 2025 |
| RBC Capital | Analyst unavailable | $200 | $179.28 | +4.1% | Nov 24, 2025 |
| Barclays | Alex Scott | $206 | $177.13 | +7.2% | Nov 20, 2025 |
| Roth Capital | Harry Fong | $200 | $189.59 | +4.1% | Oct 20, 2025 |
| Goldman Sachs | Analyst unavailable | $195 | $189.59 | +1.5% | Oct 20, 2025 |
| Morgan Stanley | Analyst unavailable | $195 | $189.16 | +1.5% | Oct 17, 2025 |
| Evercore ISI | Analyst unavailable | $237 | $189.8 | +23.3% | Oct 17, 2025 |
| Wells Fargo | Elyse Greenspan | $212 | $186.48 | +10.3% | Oct 17, 2025 |
| UBS | Analyst unavailable | $257 | $203.84 | +33.7% | Oct 8, 2025 |
| Barclays | Alex Scott | $221 | $203.84 | +15.0% | Oct 8, 2025 |
| Morgan Stanley | Bob Huang | $215 | $203.2 | +11.9% | Oct 7, 2025 |
| Morgan Stanley | Bob Huang | $220 | $207.74 | +14.5% | Aug 18, 2025 |
| Cantor Fitzgerald | Ryan Tunis | $256 | $204.41 | +33.2% | Aug 12, 2025 |
| UBS | Brian Meredith | $258 | $212.86 | +34.2% | Jul 21, 2025 |
| BMO Capital | Michael Zaremski | $228 | $222.06 | +18.6% | Oct 22, 2024 |
| Roth Capital | Harry Fong | $230 | $225.88 | +19.7% | Oct 18, 2024 |
| RBC Capital | Mark Dwelle | $242 | $226.92 | +25.9% | Oct 18, 2024 |
| Goldman Sachs | Robert Cox | $220 | $226.92 | +14.5% | Oct 18, 2024 |
| Bank of America Securities | Joshua Shanker | $250 | $226.76 | +30.1% | Oct 10, 2024 |
| BMO Capital | Michael Zaremski | $217 | $224.01 | +12.9% | Oct 1, 2024 |
| Barclays | Alex Scott | $236 | $231.42 | +22.8% | Sep 4, 2024 |
| Roth Capital | Harry Fong | $220 | $217.42 | +14.5% | Jul 19, 2024 |
| RBC Capital | Mark Dwelle | $228 | $210.94 | +18.6% | Jun 28, 2024 |
| RBC Capital | Mark Dwelle | $210 | $201.73 | +9.3% | Apr 19, 2024 |
| Wells Fargo | Elyse Greenspan | $213 | $201.73 | +10.8% | Apr 19, 2024 |
| Evercore ISI | David Motemaden | $221 | $201.73 | +15.0% | Apr 18, 2024 |
| Piper Sandler | Paul Newsome | $211 | $196.29 | +9.8% | Apr 17, 2024 |
| Citigroup | Analyst unavailable | $190 | $175.28 | -1.1% | Feb 1, 2023 |
| Jefferies | Analyst unavailable | $178 | $170.96 | -7.4% | Jan 9, 2023 |
| Credit Suisse | Andrew Kligerman | $157 | $165.7 | -18.3% | Dec 23, 2022 |
| Citigroup | Analyst unavailable | $185 | $168.57 | -3.7% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $150 | $169.58 | -22.0% | Nov 22, 2022 |
| Atlantic Equities | John Heagerty | $185 | $163.01 | -3.7% | Nov 8, 2022 |
| Raymond James | Analyst unavailable | $180 | $158.12 | -6.3% | Jul 22, 2022 |
| Jefferies | Analyst unavailable | $181 | $155.95 | -5.8% | Jul 12, 2022 |
| Morgan Stanley | Analyst unavailable | $163 | $149.77 | -15.2% | May 23, 2022 |
| Wells Fargo | Analyst unavailable | $183 | $157.93 | -4.8% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $164 | $175.32 | -14.7% | Apr 22, 2022 |
| Piper Sandler | Analyst unavailable | $197 | $175.76 | +2.5% | Apr 22, 2022 |
| Raymond James | Analyst unavailable | $190 | $178.7 | -1.1% | Apr 22, 2022 |
| RBC Capital | Analyst unavailable | $185 | $178.7 | -3.7% | Apr 22, 2022 |
| J.P. Morgan | Analyst unavailable | $163 | $179.6 | -15.2% | Apr 21, 2022 |
| Piper Sandler | Paul Newsome | $145 | $132.19 | -24.6% | Apr 28, 2021 |
| Deutsche Bank | Phil Stefano | $135 | $132.19 | -29.8% | Apr 28, 2021 |
Track every rating change on MRSH the moment it posts. Free to start.
Start free